REG - Spire Healthcare Grp - Director Declaration

Spire HealthcareAnnouncement

20/01/2023 09:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230120:nRST4034Na&default-theme=true

RNS Number : 4034N  Spire Healthcare Group PLC  20 January 2023

 

Spire Healthcare Group plc

 

('Spire Healthcare', 'the Company' or 'the Group')

 

Director Declaration

 

20 January 2023

 

Spire Healthcare Group plc announces that Sir Ian Cheshire, Non-Executive
Chairman of the Company, will be appointed as a Non-Executive Director and
Chair Designate of Land Securities Group plc from 23 March 2023.

 

In addition; Sir Ian will

·      step aside from the chairmanship of Menhaden Resource Efficiency
PLC on 16 May 2023 (remaining as a Non-Executive Director); and

·      step down as a Non-Executive Director of BT Group plc from the
conclusion of their annual general meeting in July 2023.

 

This announcement is made in accordance with Listing Rule 9.6.14.

 

- Ends -

 

For further information please contact:

 

 Spire Healthcare                                  +44 (0)7974 982 512

 Angus Prentice - Director of Investor Relations

 Instinctif Partners                               +44 (0)7931 598 593

 Damian Reece                                      +44 (0)7917 178 920

 Guy Scarborough

 

 

Registered Office and Head Office:

 

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

 

About Spire Healthcare

 

Spire Healthcare (https://www.spirehealthcare.com/) is a leading independent
healthcare group in the United Kingdom, with 39 hospitals and over 30 clinics
across England, Wales and Scotland. It operates a network of private GPs and
provides occupational health services to over 700 corporate clients.

 

Working in partnership with around 8,150 experienced consultants, Spire
Healthcare delivered tailored, personalised care to almost 870,000
in-patients, out-patients and day-case patients in 2021, and is the leading
private provider, by volume, of knee
(https://www.spirehealthcare.com/treatments/bones-and-joints/knee-replacement/)
and hip
(https://www.spirehealthcare.com/treatments/bones-and-joints/hip-replacement-surgery/)
operations in the United Kingdom. The Group's well-located and scalable
hospitals have delivered successful and award-winning clinical outcomes,
positioning the Group well with patients, consultants, the NHS, GPs and
Private Medical Insurance ("PMI") providers. 98% of Spire Healthcare's
inspected hospitals and clinics are rated 'Good', 'Outstanding' or the
equivalent by health inspectors in England, Wales and Scotland.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RDNBMMLTMTTTMJJ